The average selling price for SYNERGY in Norway dropped in 2022, according to GlobalData. The average selling price, the complete price range of high and low prices and a 3-year forecast for the SYNERGY device in Norway can be viewed in GlobalData’s micro pricing report. Buy the report here.
The SYNERGY is sold by Boston Scientific Corp in the Coronary Stents – DES market. Drug eluting stents (DES) release drugs locally and can be coated with a polymeric material. The stent releases an antiproliferative or immunosuppressive drug over time, leaving behind the metallic stent in the artery.
For a complete picture of Boston Scientific Corp’ Coronary Stents – DES device pricing in Norway, buy the report here.